Atul Rustgi, Partner at Accolade, discusses evaluating VC managers, fund size, and COVID-19 impact. Talks about investing in early-stage venture and late-stage growth equity funds. Reflects on the evolution of the venture capital industry from 2007. Provides insights into current environment challenges and future outlook on software and healthcare investments.
Managers focus on preserving cash and extending runway during crises, while LPs remain vigilant in decision-making.
Long-term strategy in software and healthcare sectors remains resilient for potential gains over the next decade.
Deep dives
Approach in Challenging Times
Managers focus on cutting burn and extending cash run to 12-24 months during uncertain periods, learned from past crises. Conversations shift to enhancing reserves and cautiously deploying capital. LPs remain supportive, vigilant of signals from public markets for decision-making.
Venture Capital Landscape Evolution
Anticipation of potential market corrections leads to cautious optimism. Insights point to a flight to quality, emphasizing the importance of top-performing managers. Long-term strategy stays resilient, with no immediate tactical changes. Funds focus on survival tactics and seek potential opportunities amid the crisis.
Endowment Fund Uncertainties
Endowments face revenue shortfalls due to uncertainties of students returning to campuses. Impact unclear on endowment investment strategies, with emphasis on managing risks amid shifting market dynamics. Challenges include balancing liquid investments and potential utilization of endowment funds to support universities amid lower revenue expectations.
Future Outlook for Venture Capital
Software and healthcare sectors are highlighted for long-term growth potential. Positive view on the continuous bull run of software and healthcare markets. Emphasis on strong business models and innovation in these sectors, positioning them for significant gains over the next decade. Ventures focused on software and healthcare poised for success amidst evolving market trends.
Atul Rustgi is a Partner at Accolade, working across both early-stage venture and late-stage growth equity strategies. Prior to joining Accolade in 2007, Atul worked at McKinsey & Co. and the Robin Hood Foundation.
In this episode, we discuss Atul's unique experience evaluating VC managers over the past decade, and Accolade's strategy investing in both very small early-stage venture funds and much larger late-stage growth equity funds. We also discuss Atul's deep conviction around portfolio construction, fund size, and ownership. Finally, we discuss his views on the impact of Covid-19 on the venture ecosystem today and his outlook for 2020 and beyond.
As always, a huge thank you to Carta, the title sponsor for this season of Origins. This season is also sponsored by SVB and Cooley, two of the earliest and most trusted supporters of our work at Notation.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode